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Cases of bladder leiomyosarcoma represent 0.1% of all nonurothelial tumors. We present a case report of
a 73-year-old man who underwent a radical cystoprostatectomy for a high-grade bladder leiomyo-
sarcoma with an ileal diversion. The patient recovered uneventfully and no surgical margins were
veriﬁed in ﬁnal pathology. Early follow-up at 3 months shows no signs of computed tomography
recurrence and adequate adaptation to ileal diversion. Although bladder sarcomas were once thought to
have a grim prognosis, recent studies suggest that adequate surgical treatment is able to achieve optimal
cancer control outcomes.
 2014 The Authors. Published by Elsevier Inc. All rights reserved.Introduction
Nonurothelial neoplasms of the bladder account for <5% of all
bladder tumors. Urinary bladder leiomyosarcoma is a very rare
diseasewith few cases reported in literature. Given its scarcity, little
is known about its etiology and consensus is lacking on therapeutic
management. Herein, we present the case of a patient diagnosed
with a bladder leiomyosarcoma and treated with radical cys-
toprostatectomy and ileal diversion.Case presentation
A 73-year-old man with medical history of hypertension and a
transurethral resection of the prostate consulted for gross hema-
turia. The patient did not have history of any radiotherapy or
chemotherapy treatment. Physical examination revealed a suspi-
cious pelvic mass. A contrast-enhanced computed tomography (CT)
scan showed awell-deﬁned, heterogeneous, enhancing endophytic,
5-cm bladder tumor on the right anterior wall with no upper tract
obstruction (Fig. 1).
The patient underwent a complete transurethral resection of the
tumor. Surgical pathology showed a possible sarcomatoid carci-
noma without excluding the possibility of a bladder leiomyo-
sarcoma. Thoracic CT scan and bone scintigraphy were normal.
Patient was referred to our institution, where radical surgicalBY-NC-ND license (http://
þ33 156616640.
i).
Published by Elsevier Inc. All rightreatment was indicated. The patient underwent a laparoscopic
radical cystoprostatectomy with ileal conduit urinary diversion and
an extended pelvic lymph node dissection. Final pathologic exam-
ination showed an invasive 6-cm high-grade myxoid leiomyo-
sarcoma (Figs. 2, 3) with negative surgical margins and no lymph
node metastasis (0/12).
On postoperative day 8, the patient was reoperated because of
evisceration without any signiﬁcant abdominal ﬁnding. The patient
recovered uneventfully and experienced complete resolution of his
urologic symptoms. The follow-up CT scan 3 months after surgery
showed no sign of recurrence.
Discussion
Only about 100 cases of bladder leiomyosarcoma have been
reported in the literature, which represent 0.1% of all nonurothelial
tumors.1 Sarcoma constitutes the most usual mesenchymal malig-
nancy of the bladder with leiomyosarcomas being the most com-
mon type of sarcomas in adults.2 Gross hematuria is the most
common presenting symptom with more than 80% of the cases.1,3
There is strong evidence that the incidence of leiomyosarcomas is
increased in patients receiving pelvic radiotherapy or systemic
chemotherapy such as cyclophosphamide.2,3 On the other hand,
tobacco use seems not to increase the incidence of bladder
leiomyosarcomas.2
There is no general consensus on the treatment, but it is
considered as a highly aggressive entity that requires an aggressive
surgical extirpation with wide margins. The best prognostic factor
is the presence of tumor-free margins.1,2,4 In the 1992 Memorial
Sloan-Kettering Cancer Center study examining adult urologic
sarcomas, Russo et al4 included other favorable prognosticts reserved.
Figure 1. Computed tomography of the pelvis with intravenous contrast showing the
mass on the right anterior part of the bladder.
Figure 3. Histologic appearance of myxoid leiomyosarcoma of the bladder.
Hematoxylin-eosin stain  630. 1, Abnormal mitosis; 2, moderately differentiated
leiomyosarcoma with a fascicular growth pattern; 3, pools of hyaluronic acid showing
the myxoid character.
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and paratesticular or bladder tumor site. The Memorial Sloan-
Kettering Cancer Center sarcoma staging was able to predict sur-
vival in these patients, suggesting a behavioral similarity between
urologic sarcomas and other soft tissue sarcomas.
The standard surgical technique (en bloc removal of the bladder
with prostate and seminal vesicles in men and the uterus, cervix,
and vaginal cuff in women, including a bilateral pelvic lymph node
dissection) may result in low rates of positive surgical margins and
low rates of local tumor recurrence. It is also recommended to
completely remove the urachus and perivesical fat enveloping the
upper hemisphere of the bladder.4 Patients with locally advanced
disease might beneﬁt from neoadjuvant chemotherapy which
would ultimately allow a radical surgery.5 Minimally invasiveFigure 2. Histologic appearance of myxoid leiomyosarcoma of the bladder.
Hematoxylin-eosin stain  25. 1, Normal urothelium; 2, massive invasion of the
muscularis propria.treatment such as transurethral resection and adjuvant chemo-
radiation is an alternative for patients refusing a radical treatment
andmust be used for patients with small tumors. Partial cystectomy
with sole resection of the mass should be considered as a palliative
treatment and is only possiblewith certain locations of the tumor.1,2
Contemporarystudies suggest that these tumorsmayhaveabetter
prognosis with 5-year disease-speciﬁc survival rates of 84% making
bladder leiomyosarcoma survival rates better than the rates for pa-
tients with sarcomas of other organs.4 The overall local recurrence
rate is about 16% and most recurrences are seen in the pelvis.1,2 Local
recurrences should be treated with systemic chemotherapy and/or
pelvic external radiotherapy.2 Although bladder sarcomas were once
thought to have a grimprognosis, it seems that somepatients are able
to achieve long-term survival, especially if an adequate surgical
approach is deployed as primary treatment.Conclusion
Leiomyosarcomas of the bladder have always been considered as
a highly aggressive disease with poor prognosis. We present the
case of a high-grademyxoid leiomyosarcoma primarily treatedwith
minimally invasive surgery and harboring negative margins in ﬁnal
pathology. Recent studies suggest that radical surgery results in low
rates of positive margins and low rates of local tumor recurrence.
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